Criterion and Convergent Validity of Activity Monitors to Study Walking Activity
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Validity Study of Activity Monitors in Healthy Subjects
- Sponsor
- University of Rennes 2
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Detection rate of daily life walking bouts
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
Wearable activity monitors represent a real opportunity to assess people' daily walking activity, however their level of validity remains poorly understood in the assessment of intermittent walking activity, i.e. as it occurs in everyday life conditions. Indeed, the available validation studies mainly focused on steps count accuracy of wearable activity monitors, but their validity to detect and quantify bouts of intermittent walking in daily life conditions remains insufficiently studied. It is important not only to determine which indicators would be the most accurate but also which methods would be the most suitable for detecting intermittent walking bouts, and then estimating energy expenditure. The main objective of the VAMOS project is to study the criterion and convergent validity of consumer-level and research-grade wearable activity monitors in assessing daily life intermittent walking in healthy subjects.
Investigators
Alexis LE FAUCHEUR
Associate professor
University of Rennes 2
Eligibility Criteria
Inclusion Criteria
- •Be at least 20 years old and under 80 years old.
- •Have understood the objectives of the study and its constraints.
- •Have read and signed a free and informed consent.
- •Be affiliated to the French social security system
Exclusion Criteria
- •Known contraindications or limitations to walking, and reported by the participant.
- •Case of hypertension, heart failure, angina pectoris, diabetes, chronic obstructive pulmonary disease, proven by the presence of medication in relation to these diseases and the medical history reported by the participant.
- •Case of factors, medical treatments, or diseases likely to lead to a functional limitation to walking and/or a significant modification of the physiological responses to exercise, e.g. active smoking (ongoing or weaned for less than six months), cancer (ongoing), Parkinson's disease, kidney failure (ongoing), proven by the presence of medication in relation to these diseases and the medical history reported by the participant.
- •History of cardiovascular disease (heart failure, stroke, heart attack myocardium...) reported by the participant.
- •Woman with known ongoing pregnancy (self-declared) or breastfeeding woman.
- •Adults subject to legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty.
- •Simultaneous participation in another research involving the human person.
- •Consent withdrawal during the study.
- •Any health concern that would appear during the study and that no longer would allow the person to continue to participate.
Outcomes
Primary Outcomes
Detection rate of daily life walking bouts
Time Frame: 8 days
Detection rate of daily life walking bouts by wearable activity monitors
Error level in the estimation of walking energy expenditure
Time Frame: 1 day
Error level in the estimation of walking energy expenditure by wearable activity monitors